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Abstract 
Background: Homeostatic leukocyte trafficking into and within the female reproductive tract 
(FRT) contributes to fertility and reproductive health.  It is unclear how this process is regulated 
in the anatomically distinct reproductive tissues, or whether the genes involved are affected by 
cyclical changes in reproductive hormones.  In tissues such as skin and intestine, mouse studies 
have defined evolutionarily conserved molecular mechanisms for tissue-specific homing, 
interstitial positioning, and leukocyte egress.  Chemokine family members are invariably 
involved, with the chemokine expression profile of a tissue regulating leukocyte content.   
Methods:  Reproductive tissues (ovary, vagina, cervix, uterine horn) of 8 week old virgin 
female C57BL/6 mice (n=20) were collected, and expression of mRNA for leukocyte markers 
and chemokines conducted by qPCR. Lymphocytic and myeloid cell populations within the 
uterus, cervix, bone marrow and PALN from virgin C57BL/6 mice was determined by flow 
cytometric analysis.   
Results: Variation in leukocyte content between reproductive tissues is evident, with the uterus 
and cervix containing complex mixtures of lymphocytes and myeloid cells. Twenty-six 
chemokine genes are expressed in the FRT, many by several component tissues, some 
preferentially by one. Most striking are Xcl1 and Ccl28, which are restricted to the uterus.  
Ccl20 and genes encoding CXCR2 ligands are primarily transcribed in cervix and vagina. 
Ovary shows the lowest expression of most chemokine genes, with the notable exception of 
Ccl21 and Ccl27.  We also identify eight chemokines in the vagina whose expression fluctuates 
substantially across the estrous cycle.  
Conclusion: These data reveal complex chemokine networks within the female reproductive 
tract, and provide a framework for future studies of homeostatic leukocyte trafficking into and 
within these tissues. 
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Introduction 
Leukocytes are abundant in bone marrow, blood and lymphoid tissues, but these key 
immune cells are also found in virtually all healthy non-lymphoid tissues under homeostatic 
conditions. There is constant movement of leukocytes into, within, and out of these tissues, and 
discrete interstitial niches often contain specialised populations of resident leukocytes. 
Collectively, these cells maintain peripheral immunological tolerance, detect tissue damage 
and infection, and initiate the innate and adaptive immune responses that lead to tissue repair 
and immune protection. In addition, memory T cells generated during an infection are 
imprinted with specific homing properties that allow them, after homeostasis has been restored, 
to preferentially home to the tissue where the infection was first detected (Sheridan, 2011).  
Here they are ideally placed to rapidly respond if the infectious agent is encountered for a 
second time. Thus, the recruitment, positioning and departure of leukocytes is of fundamental 
importance to all tissues because they contribute to immunosurveillance, tolerance, tissue 
repair and immune memory.   
Homeostatic leukocyte migration and localisation is largely dependent on leukocytic 
expression of cell adhesion molecules and chemoattractant receptors. Heptahelical G-protein-
coupled receptors for chemokines are particularly important (Bachelerie, 2014; Hughes, 2018). 
Chemokines are a large family of small, secreted chemoattractants that are subdivided into four 
groups (CC, CXC, XC and CX3C) based on the configuration of conserved cysteine residues 
near their amino-terminus (Zlotnik, 2012).  They have been implicated in many processes 
critical for leukocyte trafficking, including arrest on blood vessel endothelium, transendothelial 
migration, interstitial motility, retention in specific tissue compartments, and departure from 
tissue via lymphatic vessels (Hughes, 2018). Some chemokines are constitutively expressed by 
many non-lymphoid tissues where they contribute to common migratory processes. For 
instance, CCL21 is widely expressed because it mediates the steady state egress of dendritic 
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cells (DCs), a process that happens in many tissues (Johnson, 2010; Tal, 2011).  Other 
chemokines show a more restricted pattern of expression and are responsible for recruiting 
leukocyte populations with critical tissue-specific functions. This has been particularly well 
studied in the skin and intestine of mice. For example, CCL8 is abundantly produced in resting 
skin (Islam, 2011), while CCL25 is found almost exclusively in the small intestine (Campbell,  
2002).  As a consequence, leukocytes expressing CCR8, the CCL8 receptor, have the potential 
to home to the skin, while those expressing the CCL25 receptor CCR9 can enter the wall of the 
small intestine. Chemokine receptor expression is used to define the migratory potential of a 
leukocyte and identify discrete populations of cells with shared functional properties. Similarly, 
the chemokine expression profile of a tissue gives a clear indication of which molecular 
pathways are likely to play critical roles in regulating its leukocyte infiltrate. Importantly, while 
most studies of leukocyte homing have been performed in mice, the pathways that have been 
characterised to date appear to be conserved in other mammals, including humans (Nomiyama, 
2013). 
  The female reproductive tract (FRT) consists of several anatomically and functionally 
distinct tissues, each containing discrete microanatomical compartments. These tissues are 
subject to fluctuations in female sex hormones that drive a cyclical pattern of fertility. In mice 
this estrous cycle lasts 4-5 days and is split into four main phases: proestrus, estrus (during 
which ovulation occurs), metestrus and diestrus (Byers, 2012; Bertolin, 2014).  Progress 
through the estrous cycle is accompanied by alterations in the structure and leukocyte content 
of FRT tissues. In these tissues, as in other tissues, leukocytes will contribute to 
immunosurveillance, immunological tolerance, tissue repair and post-infection immune 
memory. They will also initiate the immune and inflammatory responses that are associated 
with key reproductive processes, such as implantation (Pijnenborg, 2002; Garlanda, 2008; 
Dekel, 2014), placentation (Spencer, 2014), parturition (Thomson, 1999; Bollapragada, 2009) 
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and post-partum involution (Shynlova, 2013). Abnormal inflammation in the FRT is associated 
with gynaecological conditions and reproductive problems in humans, including polycystic 
ovarian syndrome (Ojeda-Ojeda, 2013; Schmidt, 2014), endometriosis (Maybin, 2011; Laux-
Biehlmann, 2015), pre-eclampsia (Spencer, 2014), ovarian cancer (Singh, 2016; Sanguinete, 
2017) and preterm labour (Romero, 2006; Blank, 2008; Ito, 2010; Phillips, 2014). Despite the 
evident physiological and pathological importance of leukocytes in the tissues of the FRT, the 
mechanisms that control the homeostatic trafficking of these cells into, within, and out of these 
tissues in mice and humans are largely unknown.  
We hypothesised that to regulate constitutive leukocyte trafficking, tissues of the FRT 
will have overlapping chemokine gene expression profiles that may fluctuate over the course 
of the estrous cycle. To examine this, we have defined the steady state chemokine gene 
expression profile of the four major tissues of the mouse FRT, and compared this to equivalent 
data generated from skin, small intestine and colon, whose homeostatic chemokine profiles 
have been more widely studied. We have also examined how the expression of each chemokine 
gene is modulated over the course of the estrous cycle. Remarkably, we find that 26 different 
chemokine genes are expressed in the FRT under homeostatic conditions. Some are highly 
restricted to, or preferentially expressed in, one tissue of the FRT, while others show equivalent 
expression in two or more tissues. We also show that, in the vagina, the estrous cycle modulates 
the expression of 8 chemokine genes, 7 of which peak during diestrous and/or metestrous. 
Collectively, these data reveal the complexity of chemokine networks within the FRT, and 
provide a framework for future investigation of the mechanisms directing homeostatic 
leukocyte trafficking and localisation in its component tissues. 
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Methods 
 
Animals and tissue collection 
All animal experiments were approved by the University of Glasgow ethical review committee 
and were performed under the auspices of UK Home Office licences (Home Office Project 
Licence number 60/3765).  All work used 8-week old virgin female C57BL/6 mice maintained 
in specific pathogen-free conditions at the University of Glasgow’s Central Research Facility. 
Estrous cycle stage (proestrus, estrus, metestrus or diestrus) was determined by vaginal 
appearance and microscopic examination of the cellularity of vaginal lavage, as previously 
described (Caligioni, 2009).   The ovary, vagina, cervix and mid portions of each uterine horn, 
along with dorsal skin, small intestine and colon, were collected into RNAlater® before snap 
freezing in liquid nitrogen and storing at -80oC.  Cycle assessment and tissue collection were 
performed at the same time each morning to ensure consistency. 
 
RNA isolation and complementary DNA synthesis 
Each frozen tissue biopsy was homogenized in 1ml of TRIzol® reagent (Thermo Fisher 
Scientific, Paisley, UK) using an Omni µH homogenizer (Omni International, Kennesaw, 
USA).  Total RNA was extracted according to the manufacturer’s instructions, and quantified 
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific).  A260/280 was 
recorded for each sample as a measure of purity.  RNA quality was assessed by gel 
electrophoresis: all samples showed tight 28S and 18S rRNA bands, indicating that minimal 
degradation had occurred during the isolation process (data not shown).  5µg of RNA was 
treated with DNAse-I using the DNA-freeTM kit (Life Technologies).  To synthesise cDNA, 
the High Capacity Reverse Transcription Kit was used (10µl final reaction volume) (Thermo 
 8 
Fisher Scientific).  Control samples were also prepared in which reverse transcriptase was 
omitted from the reaction (i.e. –RT control). 
 
Gene expression analysis by quantitative PCR (QPCR) 
The expression of genes encoding leukocyte markers was quantified using Taqman® 
technology on the ABI Prism 7900HT system (Applied Biosystems) and SDS Version 2.3 
software. Gene expression assays used are listed in Table 1. Into each well, 1.25µl 20X target 
or endogenous control assay was added, along with 12.5µl Taqman® Universal Mastermix 
(Thermo Fisher Scientific), 10.25µl molecular grade water (Sigma Aldrich, St. Louis, USA) 
and 1µl of the cDNA reaction. Reactions were incubated for 2min at 50oC, 10min at 95oC, 
followed by 40 cycles of 95oC (15sec) and 60oC (1min). In all experiments, negative controls 
were performed in which cDNA was replaced with water or with an aliquot of the ‘–RT control’ 
reaction: these samples consistently failed to generate any PCR product. The formula 2-Cq was 
used to determine relative expression (Livak, 2001) in comparison to the endogenous control 
gene, Gapdh, and fold change calculated relative to ovary, which was given the arbitrary value 
of 1. Of those endogenous control genes examined, Gapdh gave the most consistent Ct values 
between samples and tissues (data not shown).  
 
Preparation of single cell suspensions  
Uterine horn or cervix was minced with scissors in 7ml or 3ml, respectively, of Hank’s 
Balanced Salt Solution (Sigma) (with Ca2+ and Mg2+) containing 0.026 Wunsch Units/ml 
Liberase TM (Roche) and 50µg/ml DNase I (Roche), and then incubated for 40min at 37oC 
with gentle continuous shaking. The digested tissues were then mashed through a cell strainer 
using the plunger of a 2ml syringe. The strainer was then washed with complete RPMI (i.e. 
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RPMI containing 2mM L-glutamine and 10% heat-inactivated foetal calf serum). Bone marrow 
(BM) aspirates were prepared by dissecting the femurs from mice, cutting off each end of the 
bone, and flushing out the cells with 1ml of complete RPMI using a syringe. Single cell 
suspensions of the para-aortic lymph node (PALN) were prepared by mashing the node through 
a cell strainer in complete RPMI using the plunger of a 2ml syringe. All samples were 
centrifuged at 400g for 5min at 4oC, washed once with complete RPMI, resuspended in ice-
chilled FACS buffer (PBS containing 1% foetal calf serum, 5mM EDTA and 0.02% sodium 
azide), and stored at 4oC in preparation for immunostaining.   
 
Immunostaining and flow cytometry 
Cells in FACS buffer were incubated in Fc Block (BD Biosciences) for 15mins at 4oC, washed 
with FACS buffer, and stained for 15mins at 4oC in fluorescently labelled antibodies. After two 
washes with FACS buffer, cells were incubated for 10mins with Viaprobe (BD Biosciences) 
(to allow subsequent identification of dead cells) and then passed through a Nitex filter into a 
FACS tube. Antibodies against the following proteins were used according to the supplier’s 
instructions (fluorophores are indicated in parentheses): CD45 (APC-Cy7), F4/80 (PE-Cy7), 
CD4 (PE-Cy7), and CD8 (PE) (all from eBiosciences), and CD11b (V450), Ly6C (FITC), CD3 
(VioBlue), CD25 (FITC) (all from BD Biosciences). Data were acquired on a MACS Quant 
flow cytometer (Miltenyi Biotec). Acquisition parameters were set using (i) anti-mouse Ig 
k/negative control CompBeads (BD Biosciences), (ii) samples stained with a single antibody, 
and (iii) fluorescence minus one controls (in which one fluorescent antibody in the mixture was 
omitted). Data were analysed using FlowJo software (Tree Star). During analysis, we excluded 
cell debris by pre-gating using physical properties (forward scatter (FSC) and side scatter 
(SSC)), and discounted dead cells by selecting for Viaprobe-negative cells. Cells doublets and 
higher order aggregates were excluded by plotting FSC area against FSC height. The various 
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control samples were then used to set gates to identify cells expressing a particular protein, or 
set of proteins. 
 
Gene expression analysis by Taqman® Gene Expression Array Cards 
Custom Taqman® Gene Expression Array Cards (Thermo Fisher Scientific) were designed to 
include target assay mixes for the endogenous control gene, Gapdh, and for all chemokines 
expressed by C57BL/6 mice that are known to directly regulate leukocyte migration (Table 2). 
For each sample, we combined cDNA transcribed from 1µg RNA, molecular grade water and 
Taqman® Universal Mastermix to give a final volume of 100µl and added this to the 
appropriate well of the array card. All cards contained negative controls in which cDNA was 
replaced with water or a –RT control sample: these samples consistently failed to generate any 
PCR product. Cards were centrifuged twice for 1min at 500g, before being placed in the ABI 
Prism 7900HT system using SDS Version 2.3 software. For analysis, DataAssistTM Version 
2.0 was used. In all analyses, the formula 2-Cq was used to determine relative expression (Livak, 
2001) in comparison to the Gapdh, and fold change calculated relative to ovary, which was 
given the arbitrary value of 1.    
 
Determination of CCL27 protein concentration by ELISA 
Ovary and uterus were removed from C57BL/6 mice, snap frozen in liquid nitrogen and stored 
at -80oC. Tissues were weighed and Cell Lytic MT solution (Sigma) containing protease 
inhibitors (Roche) added (20ml per gram of tissue). Tissues were homogenised and lysates 
cleared of debris by centrifugation at 13000rpm for 10min at 4oC. Supernatant was collected 
and stored at -20oC. CCL27 concentration was measured using a DuoSet ELISA kit (R&D 
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systems) according to the manufacturer’s instructions and is presented as amount of chemokine 
(pg) per mg of tissue. 
 
Statistical Analysis 
Differences between more than two groups were examined using the Kruskal-Wallis test, 
followed by a post hoc Dunn’s test.  Comparisons between two groups were determined using 
the Mann-Whitney Test. p<0.05 was considered statistically significant.   
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Results  
The tissues of the FRT differentially express markers of specific leukocyte populations 
First, to get an indication of differences in leukocyte content between tissues of the 
FRT, we compared their expression of genes encoding established markers of T cells (gamma 
polypeptide of CD3), B cells (CD19), natural killer (NK) cells (CD49b), DCs (CD11c), 
macrophages (F4/80), neutrophils (Neutrophil Granule Protein (NGP)) and eosinophils (Major 
Basic Protein (MBP)) in the ovary, uterus, cervix and vagina of virgin C57BL/6 mice (Table 
1). Many of these proteins are widely used in flow cytometry and immunohistology to identify 
specific leukocyte populations in lymphoid and non-lymphoid tissues of mice and to our 
knowledge, there is no evidence to suggest that they are expressed by non-leukocytic cells in 
the FRT or elsewhere. Moreover, analysis of data from the Immunological Genome Project 
(www.immgen.org) confirmed the highly restricted expression of the genes encoding these 
proteins by the expected leukocyte subset (data not shown). However, it should be noted that 
macrophages can produce low to intermediate amounts of CD11c (Murray and Wynn 2011) 
and eosinophils can express F4/80 (Diener et al. 2016). With the exception of Cd19, all other 
genes were detectably expressed in the FRT (Figure 1 and data not shown). Moreover, there 
was clear evidence of variation in their expression between tissues of the FRT. Most notable 
was the uterus, which compared to other FRT tissues showed highest expression of the genes 
encoding F4/80, CD11c, MBP or CD3g (Figure 1A-D). The uterus, along with the cervix, also 
showed highest expression of Itga2 (which encodes CD49B), the NK cell marker (Figure 1E). 
Compared to the vagina, the cervix had significantly higher expression of the genes encoding 
F4/80, CD11c, or MBP (Figure 1A-C), while the neutrophil marker Ngp was preferentially 
expressed by the vagina and cervix (Figure 1F). Thus, the tissues of the FRT vary in their 
expression of specific markers of major leukocyte subsets suggesting that, as expected, they 
vary with respect to their resident leukocyte populations. 
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Uterus and cervix contain diverse populations of lymphocytes and myeloid cells. 
To explore the diversity of leukocyte content in the FRT, we performed flow cytometry 
on single cell suspensions of uterus and cervix (Figure 2). These two tissues showed the highest 
level, and greatest diversity, of leukocyte marker expression (Figure 1), and, in preliminary 
analysis, proved to be more amenable than ovary and vagina to analysis by flow cytometry 
(data not shown). To aid gate setting, and to act as positive controls, leukocyte-rich BM 
aspirates or single cell suspensions of the PALN (through which FRT lymph drains) were 
included in experiments examining myeloid cells or CD3+ cells, respectively.  
As expected, many BM cells and virtually all PALN cells expressed the pan-leukocyte 
marker, CD45. A proportion of cells isolated live from cervix and uterus were also CD45+ 
(Figure 2). A large fraction of these FRT leukocytes carried CD11b, a protein expressed by all 
myeloid cells (Figure 2A). In BM, the CD11b+ myeloid population can be split according to 
expression of F4/80 and Ly6C into F4/80+ macrophages/eosinophils, F4/80-Ly6Chi monocytes, 
an F4/80- Ly6Clo population (that contains mostly neutrophils and their precursors), and a small 
F4/80-Ly6C- subset likely to contain other granulocytic cells. Equivalent subsets of CD11b+ 
myeloid cells were also identifiable in the cervix and uterus, indicating that these tissues 
contain various populations of cells of the monocyte/macrophage and granulocytic lineages 
(Figure 2A).  
Guided by parallel analysis of PALN, it was also clear that CD3+ leukocytes were 
present in the uterus and the cervix (Figure 2B). As expected, most CD3+ cells in the PALN 
were either CD4+ or CD8+, and equivalent populations of cells were also present in the uterus, 
although their expression of CD4 and CD8 was somewhat lower than that seen in the PALN. 
As expected, virtually all these CD4+ and CD8+ cells expressed a T cell receptor containing the 
alpha and beta chains (TCRab) (data not shown). As previously reported (Johansson, 2003), 
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there was also a significant population of CD4-CD8- ‘double negative’ (DN) CD3+ cells in the 
uterus. In the cervix, CD4+CD3+ cells were present, but CD8+CD3+ cells were rare, and most 
CD3+ cells in this tissue were DN. CD3+CD4+CD25+ cells were rare in PALN, uterus and 
cervix. Cells co-expressing CD3, CD4 and CD25 in mice are typically either regulatory T cells 
(Tregs) or recently-activated CD4+ T helper cells. However, although previous work has shown 
that CD25 is almost always co-expressed with the Treg marker FoxP3 in CD3+CD4+ cells in 
the non-pregnant mouse uterus (Kallikourdis, 2007), expression of FoxP3 would need to be 
specifically analysed before the uterine and cervical CD3+CD4+CD25+ cells we have detected 
can be definitively identified as FoxP3+ Tregs. Any FoxP3-negative CD3+CD4+CD25+ cells 
present could be recently-activated CD4+ T helper cells, FoxP3- Tregs, or another FoxP3-
CD3+CD4+CD25+ cell type. Consistent with previous work (Johansson, 2003), the abundant 
DN CD3+ cells in uterus and cervix, but not those in the PALN, were CD25+ (Figure 2B). 
Further analysis of the DN CD3+ population in the FRT (data not shown) revealed that it 
contained some gd T cells (TCRgd+) and NKT cells (TCRab+NK1.1+), but the majority (>60%) 
resembled the unconventional, extrathymically-derived, regulatory TCRab+ T cells previously 
reported to be abundant within the murine FRT (Johansson, 2003). 
Collectively, the gene expression and flow cytometry data shown in Figures 1 and 2 
indicate that, under homeostatic conditions, the tissues of the FRT carry a diverse repertoire of 
leukocyte populations. In addition, comparisons of different tissues within the FRT provide 
evidence of regional specialisation in leukocyte recruitment and/or retention, which was to be 
expected given the differences in function, microbial exposure and immunological pressure 
that exist between the discrete components of the FRT.  
 
>70% of chemokine genes are expressed in tissues of the FRT 
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Chemokines are likely to contribute to leukocyte trafficking into, within, and out of the 
tissues of the FRT. In order to gain an unbiased and comprehensive overview of constitutive 
chemokine expression in these tissues, Taqman® Gene Expression Arrays were used to analyse 
the expression of the 34 chemokine genes in C57BL/6 mice that are known to directly control 
leukocyte migration (Table 2). This was done using RNA prepared from ovary, uterus, cervix 
and vagina, and matched samples of skin, colon, and small intestine: these non-reproductive 
tissues are known to constitutively express several chemokine genes and chemokine-driven 
tissue-specific homing to these tissues is particularly well-defined, with known involvement of 
ligands for CCR4, 8, 9 or 10. Expression of Gapdh, an endogenous control gene, was used to 
normalise the data.  Transcripts from the Cxcl9, Cxcl10, Cxcl13, Cxcl15, Ccl19, Ccl24, Ccl25 
and Ccl26 genes were either not present or were barely detectable in any FRT tissue, despite, 
in most cases, being readily detectable in at least one of the three non-reproductive tissues (e.g. 
Ccl25 in the small intestine; Ccl24 in the skin) (data not shown). These genes were therefore 
excluded from further analysis. Remarkably, however, the other 26 chemokine genes (>70% 
of those analysed) were clearly expressed in one or more FRT tissue, particularly the uterus, 
cervix and vagina. These data are shown in Figures 3-5, and described in more detail below: 
chemokines have been clustered according to the nature of their expression profile within the 
FRT. Amongst FRT tissues, the ovary showed the lowest expression of virtually all the 
chemokines. Thus, for clarity and consistency, the mean expression of each chemokine in this 
tissue was given an arbitrary relative expression value of 1, and gene expression in all other 
tissues adjusted accordingly. 
 
In the FRT, the uterus shows highest expression of many chemokines 
The predominant chemokine gene expression profile we found was one in which the 
uterus had higher expression than other FRT tissues (Figures 3 & 4).  
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Four chemokines – Ccl1, Ccl5, Ccl28, and Xcl1 – showed significantly higher 
expression in uterus than the other three FRT tissues (Figure 3). Most notable were Xcl1 and 
Ccl28, which showed ~20-fold higher expression in the uterus than other FRT tissues. There 
was also a small (2-3-fold), but statistically significant, increase in Ccl1 and Ccl28 expression 
in vagina compared to cervix.  
Six other chemokines (Ccl2, Ccl6, Ccl9, Ccl12, Cxcl14, and Cxcl16) were significantly 
higher in uterus than ovary and vagina. They also seemed to be more abundant in uterus than 
cervix, but differences between these two tissues were not statistically significant (Figure 4A). 
Of these six chemokines, Ccl6, Cxcl14 and Cxcl16 were expressed at a significantly higher 
level in cervix than vagina.  
Expression of three other chemokines - Cx3cl1, Cxcl12 and Ccl8 - also appeared to be 
highest in uterus (Figure 4B). Statistical analyses revealed that uterus expressed more Cx3cl1 
than cervix and vagina, and more Cxcl12 than vagina. Ccl8 expression was not significantly 
different between uterus, cervix and vagina, but these tissues all expressed more Ccl8 than 
ovary.   
Comparisons to the non-reproductive tissues were also informative (Figures 3 & 4). 
The uterus expressed Ccl1 and Ccl8 to a level equivalent to the skin: CCL1 and CCL8, both 
ligands for CCR8, are known to control the trafficking of leukocytes in skin (Qu, 2004; 
Schaerli, 2004; Gombert, 2005; Islam, 2011; McCully, 2015).  Ccl6, Ccl28 and Cx3cl1 were 
prominently expressed in the intestine, where indispensable functions for these chemokines or 
their receptors have been defined (Hieshima, 2004; Feng, 2006; Kotarsky, 2010; Hadis,  2011; 
Medina-Contreras,  2011; Schneider, 2015).  Ccl28 expression in the uterus was similar to that 
seen in the intestine, while Ccl6 and Cx3cl1 were only ~2-fold lower in uterus than intestine. 
Although there were no striking differences between skin, small intestine and colon with 
respect to expression of Ccl2, Ccl9, Ccl12, Xcl1, Cxcl12, Cxcl14 and Cxcl16, it was notable 
 17 
that these chemokines were all expressed in the uterus to a level that was similar to, or higher 
than, these non-reproductive tissues. Amongst the seven tissues examined, Xcl1 could be 
classified as being the most uterus-specific chemokine. Finally, it is worth noting that, in 
addition to showing preferential expression in the uterus within the FRT, Ccl5 was 
unexpectedly found to be ~10-fold more abundant in the small intestine than the colon. 
Thus, of the many chemokine genes expressed in the FRT, 13 show evidence of 
preferential expression in the uterus. The chemokine expression profile of the cervix bore 
closest resemblance to the uterus. Several of the chemokines expressed by the uterus have well 
defined roles in the skin and intestine, and uterine expression levels were comparable to those 
seen in these non-reproductive tissues.  
 
Identification of chemokines preferentially expressed in ovary, cervix and/or vagina 
 In addition to the 13 chemokine genes discussed above, another 13 were detectably 
expressed by the tissues of the FRT (Figure 5A-E). Although many of these were expressed in 
the uterus, expression by other FRT tissues matched or exceeded uterine expression, and a 
variety of distinct expression profiles were apparent.  
 Ccl3, Ccl4, Ccl7 and Ccl11 were each expressed at an equivalent level in uterus and 
cervix (Figure 5A). The vagina also expressed Ccl3 and Ccl4, but there was a marked reduction 
in expression of Ccl7, and particularly Ccl11, between cervix and vagina. Ccl17 and Ccl22, 
which encode the only chemokines able to activate the CCR4 receptor, had similar expression 
profiles within the tissues of the FRT, peaking in the cervix (Figure 5B). Each of these six 
chemokines was expressed by one or more FRT tissue at a level comparable to, or higher than, 
skin, colon and small intestine (Figure 5A-B).  
 Cxcl1, Cxcl2, Cxcl5 and Cxcl7, which all encode ligands for the CXCR2 receptor, were 
also strongly expressed by the cervix (Figure 5C). Transcripts encoding CXCL1 were ~6-fold 
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more abundant in cervix than uterus and ovary, but this increased to 200-3,000-fold when 
Cxcl2, Cxcl5 and Cxcl7 were examined. The vagina also strongly expressed these three 
chemokines: Cxcl2 expression was similar between the two tissues, although Cxcl5 and Cxcl7 
transcripts were ~3-fold lower in vagina than cervix. Transcripts encoding these four 
chemokines were barely detectable in skin or intestine. 
 Ccl20, which encodes the only chemokine able to activate the CCR6 receptor, also 
showed preferential expression by cervix and vagina (Figure 5D). It was the only chemokine 
for which the vagina appeared to be richest source of expression, although variation in 
expression between individuals meant that the difference between cervix and vagina failed to 
achieve statistical significance.  
 Finally, there were two chemokines for which the ovary was not the lowest expressing 
tissue of the FRT. These were Ccl21 and Ccl27 (Figure 5E). Both were expressed at a similar 
level in ovary and uterus, but Ccl21, and particularly Ccl27, were more strongly expressed in 
ovary than cervix or vagina. The unexpected expression of Ccl27 in the ovary was examined 
further by quantifying CCL27 protein by ELISA in lysates of ovarian and uterine tissue (Figure 
5F). CCL27 was detected in the uterus, but even more of it was present in ovary lysates with, 
on average, ~110pg of CCL27 per mg of tissue. 
 Thus, a number of chemokine genes show broad expression within the FRT, or 
preferential expression in the cervix and vagina. The ovary typically shows the lowest level of 
chemokine gene expression, but it does have a relatively high abundance of Ccl21 and Ccl27 
transcripts and produces appreciable amounts of CCL27 protein. 
 
Changes in chemokine expression in the vagina during the estrous cycle 
Next, to explore the impact of the estrous cycle on chemokine gene expression, the data 
for each individual tissue was split into four groups based on the cycle stage of the mice at the 
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time of tissue harvest i.e. proestrus, estrus, metestrus or diestrus. This had been determined by 
microscopic examination of vaginal lavage collected prior to dissection (Caligioni 2009). In 
uterus, skin, colon and small intestine, we did not detect any statistically significant changes in 
the expression of any of the chemokine genes over the course of the estrous cycle (data not 
shown). In the cervix, Ccl7 was the only chemokine gene whose expression we found to 
detectably vary across the cycle, with a statistically significant reduction from proestrus to 
estrus (Figure 6A and data not shown). In the ovary, the few chemokines that showed relatively 
high expression in this tissue were unaffected by cycle stage, but there was a significant 
reduction in expression of Ccl2 and Ccl4 from proestrus to estrus (Figure 6B and data not 
shown). In contrast to these other FRT tissues, we readily detected differences in vaginal 
chemokine expression over the course of the estrous cycle (Figure 6C). Ccl3, Ccl4, Ccl22, 
Cxcl1, Cxcl2, Cxcl5 and Cxcl7 were all predominantly expressed in metestrus. Expression of 
many of these genes remained high during diestrus, before plummeting in proestrus and 
remaining low during estrus. In contrast, but as seen in the cervix, Ccl7 expression in the vagina 
dropped as mice moved from proestrus into estrus. 
Thus, chemokine gene expression in several FRT tissues can fluctuate over the course 
of the estrous cycle, but it is in the vagina where these changes are most readily observed.  
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Discussion 
Homeostatic leukocyte trafficking into, within and out of the tissues of the FRT 
contributes to reproductive health and fertility. We hypothesised that each FRT tissue contains 
a unique chemokine gene expression profile, components of which might fluctuate with 
cyclical changes in reproductive hormones. Our data support this hypothesis, and highlight the 
complexity of chemokine networks in the FRT.  
There were clear differences between FRT tissues in their expression of genes encoding 
markers of specific leukocyte populations. Although these data do not provide an absolute 
quantitation of leukocyte abundance, they do indicate that there are marked differences in 
leukocyte content between the tissues of the FRT. Our flow cytometry data further illustrates 
the complex nature of this leukocyte content. For example, the CD25+CD3+ population in 
uterus and cervix contains up to five distinct cell types and there are also diverse populations 
of myeloid cells (CD45+CD11b+ cells) in these tissues, consistent with a recent report 
identifying at least nine distinct leukocyte populations in mouse uterus (Diener, 2016). These 
lymphocytes and myeloid cells, or their precursors, will have been recruited from the blood 
and then subject to interstitial cues that control localisation, retention and egress. Based on 
precedents established in non-FRT tissues, chemokines will play a major role in these 
processes. 
We found that 26 chemokine genes are detectably expressed in the FRT of 8-week old 
virgin C57BL/6 mice housed in specific pathogen-free conditions: it will be of interest to 
investigate if chemokine expression profiles vary between strains and over time (e.g. prior to 
sexual maturation, or during and after pregnancy). We found that the uterus is the dominant 
site of chemokine expression, but most chemokines are also expressed in other FRT tissues. 
However, Ccl1, Ccl5, and particularly Ccl28 and Xcl1, appear to be largely restricted to the 
uterus so may mediate migration specifically to this site. Their function in this context remains 
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largely unexplored. CCL5 might have indispensable roles in the uterus, although other 
chemokines expressed in this tissue (CCL3, CCL4, CCL6, CCL7, CCL9, CCL11 and CCL12) 
can activate one or more of the CCL5 receptors (CCR1, CCR3 and CCR5) so might be capable 
of doing the same job. Indeed, the complex interactions between these chemokines and their 
receptors may have evolved to ensure that responses cannot be readily disrupted by pathogen 
evasion strategies or host genetic variation. However, genetic deficiency in a single chemokine, 
Ccl11, is sufficient to disrupt eosinophil recruitment to the uterus, despite it expressing several 
other genes, including Ccl5, that encode chemokines capable of inducing leukocyte migration 
through CCR3, the dominant CCL11 receptor on eosinophils. Ccl11 deficiency also delays the 
onset of puberty, although estrous cycle and reproduction are not affected (Gouon-Evans, 
2001).   
CCL1, CCL28 and XCL1, encoded by other chemokine genes expressed primarily by 
the uterus in the FRT, direct leukocyte trafficking through CCR8, CCR10 and XCR1, 
respectively. CCR8 and CCR10 are also activated by CCL8 and CCL27, respectively: the genes 
encoding these chemokines are also expressed in uterus. CCR10 directs IgA-producing 
antibody-secreting cells (IgA ASCs) to the gut wall driven by the high expression of Ccl28 in 
the small intestine and colon (Pan 2000; Kunkel 2003; Lazarus, 2003; Hieshima, 2004; Ogawa, 
2004; Feng, 2006). IgA ASCs generated by intranasal or intravaginal immunisation can home 
to the uterus, but not cervix or vagina, and CCL28 neutralisation attenuates this process (Cha, 
2011). Ccl27 expressed in the uterus might contribute to this process.  
CCR10, along with CCR8, might also direct T cell homing to the uterus: they have both 
been implicated in the trafficking of leukocytes, particularly T cells, into and within the skin 
of humans and mice during homeostasis and inflammation (Reiss, 2001; Homey, 2002; Soler, 
2003; Qu, 2004; Schaerli, 2004; Gombert, 2005; Sigmundsdottir, 2007; Islam, 2011; McCully, 
2012; Nagao, 2012; McCully, 2015).  Our data show that uterus expresses Ccl1 and Ccl8 at a 
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level equivalent to skin. To our knowledge there have been no studies exploring the function 
of CCR8 and its ligands in the uterus. This is also the case for XCL1. XCR1 is the only receptor 
for XCL1 and has no other known ligands. It is highly restricted to a subset of DCs that cross-
present antigens to CD8+ T cells to initiate immune responses to viruses or tumours (Dorner, 
2009; Crozat, 2010; Crozat, 2011).  Mice lacking XCR1 or XCL1 show diminished CD8+ T 
cell responses to infection (Dorner, 2009). The XCL1/XCR1 axis also maintains intestinal 
homeostasis by controlling T cell and DC abundance in the tissue (Ohta, 2016).  We speculate 
that XCL1/XCR1 serves a similar homeostatic function in the uterus, and will contribute to 
anti-viral immune responses in the FRT. Interestingly, male antigens in seminal fluid can be 
cross-presented to CD8+ T cells (Moldenhauer, 2009) and generate tolerogenic CD4+ Tregs 
(Robertson, 2009; Guerin, 2011), so XCL1 might play important roles in preparing the uterus 
for implantation. CCL21 is also likely to be important in this regard. Acting through CCR7, it 
directs DC egress from tissues into lymphatic vessels (Girard, 2012), after which the DCs travel 
to lymph nodes where they activate or tolerize naïve T cells. 
In contrast to previous studies (Gouon-Evans, 2001; Kallikourdis, 2007; Hickey, 
2013b; Yip, 2013), we did not find any statistically significant changes in chemokine mRNA 
levels in the uterus over the course of the estrous cycle, perhaps because of variation in mouse 
age, housing conditions or strain (we used C57BL/6 rather than CD-1 (Yip, 2013) or 129/SvEv 
(Gouon-Evans, 2001)), or because any differences have been masked by our use of the whole 
tissue, rather than its individual component parts.  It is also possible that our study did not have 
the power to detect small differences in gene expression between phases, which are more likely 
to be revealed when only two phases of the cycle are compared (Yip, 2013).  It is also worth 
noting that although Diener and colleagues recently reported fluctuations in uterine leukocyte 
populations across the estrous cycle, these failed to achieve statistical significance (Diener et 
al. 2016) so a major change in chemokine expression across the cycle may not be required.  
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Ccl21 and Ccl27 are the only chemokine genes that are expressed at a higher level in 
ovary than other FRT tissues. The most likely function of CCL21 is to mediate DC migration 
out of the ovary, but roles for CCL27 are harder to predict. An important first step will be to 
identify cells in the ovary carrying functional receptors for this protein. 
A number of chemokine genes showed highest expression in cervix and/or vagina, 
including those encoding the CCR4 ligands CCL17 and CCL22, whose expression peaked in 
the cervix. CCR4 can direct T cell homing to skin (Campbell, 1999): expression of Ccl17 and 
Ccl22 in the cervix was at least twice that of skin. These chemokines may therefore contribute 
to the recruitment of the various T cell populations present in the cervix. Our finding that Ccl20 
is highly expressed in the vagina is consistent with studies showing CCL20 protein in mouse 
vaginal secretions (Hicke, 2013a). CCL20, which activates CCR6, has been proposed to drive 
the recruitment of Langerhans cell precursors into the human vaginal epithelium (Cremel, 
2005) and the keratinocyte layer of human skin (Charbonnier, 1999; Le Borgne, 2006).  CCL20 
in the vaginal fluid of Balb/c mice peaks during diestrus, and its secretion is suppressed by 
estradiol (Hickey, 2013a).  Ccl20 transcripts were not measured in this study, and, using 
C57BL/6 mice, we did not find any differences in Ccl20 expression in the vagina across the 
estrous cycle. The effect of estradiol on CCL20 secretion may therefore occur post-
transcriptionally, although Ccl20 expression might be regulated differently in Balb/c and 
C57BL/6 mice. The presence of CCL20 in vaginal secretions is interesting because high 
concentrations have direct antimicrobial properties (Yang, 2003; Guesdon, 2015).  In fact, 
many other chemokines expressed in the FRT exhibit antimicrobial properties (Wolf, 2012) 
and could conceivably regulate the vaginal microbiome.    
The other chemokine genes preferentially expressed in cervix and vagina encode 
ligands for CXCR2, a receptor that directs neutrophil migration. Vaginal expression is 
profoundly influenced by estrous cycle stage, each peaking in metestrus and diestrus, before 
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dropping dramatically as mice enter proestrus. At metestrus, neutrophils enter the vaginal 
epithelium and lumen: neutralisation of CXCR2 profoundly inhibits this process (Sonoda, 
1998), and neutrophil depletion results in a block at diestrus, suggesting neutrophil recruitment 
to the FRT is critical for progress through the estrous cycle (Sasaki, 2009).  CXCR2, and 
hormonal regulation of its ligands, is also critical in regulating neutrophil migration into the 
vaginal wall and lumen during Candida albicans infection (Lasarte, 2016) so CXCR2 appears 
to play major physiological and immunological roles in the vagina. 
Expression of other chemokines was also affected by the estrous cycle. In vagina, Ccl3, 
Ccl4 and Ccl22 transcripts peaked during diestrus and/or metestrus, while Ccl7 was suppressed 
in estrus in both cervix and vagina. Ccl3, Ccl4 and Ccl7 encode chemokines that bind to CCR5, 
but CCL3 and CCL7 can also bind to other receptors. These various receptors are expressed on 
neutrophils, monocytes, macrophages, NK cells, and some T cell populations, and further 
investigations are required to determine if they drive fluctuations in leukocyte trafficking over 
the course of the estrous cycle. 
Estrus was associated with a reduction in the expression of Ccl2 and Ccl4 in the ovary. 
Macrophages, which can be derived from blood monocytes, are the most abundant leukocyte 
in the ovary, and their presence peaks during proestrus and metestrus (Petrovska, 1996).  CCL2, 
by binding CCR2, is central to monocyte trafficking in mice, and CCL4 can also contribute so 
they could contribute to cyclical changes in ovarian macrophages by driving monocyte 
recruitment. Ovarian macrophages serve a variety of functions (Wu, 2004), and their depletion 
in mice leads to disruption of ovarian vasculature (Turner, 2011). 
In conclusion, our study has revealed the complex chemokine expression profiles of 
mouse FRT tissues under homeostatic conditions. This provides a framework for future 
investigations aimed at defining critical molecular mechanisms responsible for directing the 
trafficking and localisation of specific leukocyte populations in these tissues. It is also 
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important to note that while the principal function of chemokines is to drive the migration of 
leukocytes into, within, and out of tissues, chemokines can also control other aspects of 
leukocyte behaviour and function, as well as regulating the biology of tissue-resident cells, 
such as endothelial, epithelial and mesenchymal cells, particularly when homeostasis is 
perturbed (Hughes, 2018). It will therefore be important to determine if chemokines in the FRT 
do more than direct leukocyte trafficking. The availability of experimental tools means the 
function of chemokines in the FRT will be easiest to dissect in mice, but key mechanisms are 
likely to be conserved in other species so such studies will no doubt improve understanding of 
physiological and pathophysiological processes in the human FRT. 
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Figure Legends 
 
Figure 1: Comparative expression of leukocyte markers in the tissues of the FRT.  RNA 
was isolated from the ovary (n=20), uterus (n=20), cervix (n=19) and vagina (n=20) of virgin 
C57BL/6 mice. The RNA was converted into cDNA, and QPCR was used to compare 
expression of (A) Emr1, (B) Itgax, (C) Prg2, (D) CD3g, (E) Itga2 and (F) Ngp. The proteins 
encoded by these genes are indicated in parentheses. Expression of the Gapdh control gene was 
used to normalise the data. Data show mean relative expression ± S.E.M. with expression by 
ovary set to 1. The statistical significance of differences between FRT tissues was determined 
using the Kruskal-Wallis test followed by a post hoc Dunn’s test.  *p<0.05, **p<0.01, 
****p<0.0001. 
 
Figure 2: Uterus and cervix contain diverse populations of lymphocytes and myeloid cells. 
Single cell suspensions of uterus, cervix, bone marrow and PALN from virgin C57BL/6 mice 
were immunostained with fluorescently labelled antibodies and examined by flow cytometry. 
Cell debris, dead cells and cell doublets/aggregates have been excluded from all data shown. 
(A) Myeloid cells. Left panels: Histogram plots showing expression of CD45 on live single 
cells. Middle panels: Histogram plots showing expression of CD11b by CD45+ cells. The 
dotplots show expression of F4/80 and Ly6C by CD45+CD11b+ cells (F4/80+, Ly6Chi and 
Ly6Clo populations are labelled). (B) CD3+ cells. Left panels: Histogram plots showing 
expression of CD45 on live single cells. Adjacent panels: Histogram plots showing expression 
of CD3 by CD45+ cells. The dotplots show expression of CD8 and CD4 by CD45+CD3+ cells. 
Right panels: Overlaid histogram plots showing CD25 expression by CD45+CD3+CD4+ and 
CD45+CD3+CD4-CD8- cells. In both A and B, the numbers on the histograms and dotplots 
show the percentage of cells that fall within the region indicated by the horizontal line 
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(histograms) or within each box (dotplots). Data are representative of experiments repeated on 
at least four occasions with 3 or more mice per group.  
 
Figure 3: Four chemokines show higher expression in the uterus than all other FRT 
tissues. Comparative expression of Ccl1, Ccl5, Ccl28 and Xcl1 in ovary (n=20), uterus (n=20), 
cervix (n=19), vagina (n=20), skin (n=20), colon (n=20) and small intestine (n=20) of virgin 
C57BL/6 mice.  Expression of the Gapdh control gene was used to normalise the data. Data 
show mean relative expression ± S.E.M. with expression by ovary set to 1. The statistical 
significance of differences between tissues was determined using the Kruskal-Wallis test 
followed by a post hoc Dunn’s test. Only statistically significant differences between FRT 
tissues are shown. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
Figure 4: Nine other chemokines show preferential expression in the uterus. Comparative 
expression of (A) Ccl2, Ccl6, Ccl9, Ccl12, Cxcl14 and Cxcl16, and (B) Ccl8, Cxcl12 and 
Cx3cl1 in ovary (n=20), uterus (n=20), cervix (n=19), vagina (n=20), skin (n=20), colon (n=20) 
and small intestine (n=20) of virgin C57BL/6 mice.  Expression of the Gapdh control gene was 
used to normalise the data. Data show mean relative expression ± S.E.M. with expression by 
ovary set to 1. The statistical significance of differences between tissues was determined using 
the Kruskal-Wallis test followed by a post hoc Dunn’s test. Only statistically significant 
differences between FRT tissues are shown. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
Figure 5: Thirteen other chemokines are preferentially expressed in ovary, cervix and/or 
vagina. Comparative expression of (A) Ccl3, Ccl4, Ccl7 and Ccl11; (B) Ccl17 and Ccl22; (C) 
Cxcl1, Cxcl2, Cxcl5 and Cxcl7; (D) Ccl20; and (E) Ccl21 and Ccl27 in ovary (n=20), uterus 
(n=20), cervix (n=19), vagina (n=20), skin (n=20), colon (n=20) and small intestine (n=20) of 
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virgin C57BL/6 mice.  Expression of the Gapdh control gene was used to normalise the data. 
Data show mean relative expression ± S.E.M. with expression by ovary set to 1. The statistical 
significance of differences between tissues was determined using the Kruskal-Wallis test 
followed by a post hoc Dunn’s test. Only statistically significant differences between FRT 
tissues are shown. (F) ELISA-based quantitation of CCL27 protein in lysates of ovary and 
uterus (n=12), with statistical differences determined using the Mann-Whitney test.  *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001. 
 
Figure 6: Chemokine expression can vary with estrous cycle stage, particularly in the 
vagina. Comparative expression of (A) Ccl7 in the cervix; (B) Ccl2 and Ccl4 in the ovary; and 
(C) Ccl3, Ccl4, Ccl7, Ccl22, Cxcl1, Cxcl2, Cxcl5 and Cxcl7 in the vagina of virgin C57BL/6 
mice determined to be at P=Protestrus (n=5), E= Estrus (n=7), M=Metestrus (n=5) or 
D=Diestrus (n=3).  Expression of the Gapdh control gene was used to normalise the data. Data 
show mean relative expression ± S.E.M. with expression at proestrus set to 1. The statistical 
significance of differences between estrous cycle stages were examined using the Kruskal-
Wallis test followed by a post hoc Dunn’s test. *p<0.05, **p<0.01. 
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Figure 6 
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